Amanote Research

Amanote Research

    RegisterSign In

Using Drosophila as a Tool to Identify Pharmacological Therapies for Fragile X Syndrome

Drug Discovery Today: Technologies - United Kingdom
doi 10.1016/j.ddtec.2012.09.005
Full Text
Open PDF
Abstract

Available in full text

Categories
BiotechnologyDrug DiscoveryMolecular Medicine
Date

March 1, 2013

Authors
Sean M.J. McBrideSandra L. HollowayThomas A. Jongens
Publisher

Elsevier BV


Related search

From FMRP Function to Potential Therapies for Fragile X Syndrome

Neurochemical Research
MedicineBiochemistryCellularMolecular Neuroscience
2013English

Fragile X Syndrome

Journal of the Royal Society of Medicine
Medicine
1990English

Fragile X Syndrome

2019English

Fragile X Syndrome.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1996English

Stress Odorant Sensory Response Dysfunction in Drosophila Fragile X Syndrome Mutants

Frontiers in Molecular Neuroscience
Molecular NeuroscienceMolecular BiologyCellular
2018English

Targeted Treatments for Fragile X Syndrome

Journal of Neurodevelopmental Disorders
PediatricsCognitive NeurosciencePerinatologyNeurologyForensic MedicineChild HealthPathology
2011English

The Fragile X Syndrome.

Journal of Medical Genetics
Genetics
1991English

Modeling Fragile X Syndrome Using Human Pluripotent Stem Cells

Genes
Genetics
2016English

Dissecting Actomyosin Mechanochemistry Using Blebbistatin as a Pharmacological Tool

Biophysical Journal
Biophysics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy